Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Mifepristone versus placebo for endometriosis pain
2018-002367-26Phase 3Completed
- Sponsor
- Litaphar
- Start
- Feb 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of mifepristone in endometriosis (3 arms), sponsored by Litaphar. Primary endpoint: Co-primary efficacy endpoint. Started Feb 2019; status: completed.
02
Drugs
mifepristone
03
Conditions
endometriosis
Beyond the preview
Go deeper on 2018-002367-26.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2018-002367-26.